President Donald Trump on Saturday signed an executive order directing the FDA to “expedite their review of certain psychedelics already designated as breakthrough therapy drugs” for conditions including depression and anxiety. “It’s for a lot of people, but it’s for our military in particular,” Trump said of the order. Drugs such as psilocybin and MDMA have been shown to have promising effects on veterans with post-traumatic stress disorder who have not responded to more conventional

Tag-uri: Donald Trump